The Hospital Research Foundation (THRF) says a fond farewell and thank you to Melinda OLeary, our Chair of three years.

As a Member of the THRF Board for the last seven years, Melinda has been a passionate and dedicated leader, making an invaluable addition to the Board and bringing a wealth of insight and experience to her role.

A co-founder and consultant with Nova Systems, an Engineering and Project Management company, Melinda joined THRF as a Board Member in 2010 and since then has contributed her extensive experience in business and HR both at a board level and as former chair of the HR committee.

Having worked with Melinda for the last six years, THRF Chief Executive Officer Paul Flynn says her contribution to the organisation has been extensive and she’ll be sorely missed.

“It’s been an honour to serve as CEO with Melinda as THRF Chair for the last three years,” Paul said.

“Melinda has played an integral role in the growth of THRF over the last few years, leading us through an incredible period of growth.

“On behalf of the THRF Board and staff members, I want to thank Melinda for her years of service and leadership and wish her good luck with her future endeavours.”

We’re thrilled to announce existing Board Member Dr Stephen Rodda, Chief Executive of UniSA Ventures PtyLtd will take over as Chair.

Dr Rodda was educated at the University of Adelaide gaining a first-class honours degree, a PhD in Biochemistry and was awarded the University Medal. He has a combined 16 years of experience in the areas of scientific research, research management, technology commercialisation, investment management and corporate governance. Dr Rodda holds an MBA, is a Fellow of the Australian Institute of Company Directors and has undertaken the Advanced Management Program (AMP) at the Harvard Business School.

“Having served on THRF’s Board for four years I feel immensely proud of the researchers we support and the outcomes they achieve. But this is only possible because of you; the donors and ticket buyers in our lottery who are integral to our success,” Dr Rodda said.

“In 2018, we anticipate a year that will deliver even more hope and impact to the lives of South Australians through our ongoing support of research projects and patient care advancements that are truly lifesaving.”